KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Costar (CSGP) Cash & Equivalents (2016 - 2025)

Costar (CSGP) has disclosed Cash & Equivalents for 15 consecutive years, with $1.6 billion as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 65.11% to $1.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.6 billion, a 65.11% decrease, with the full-year FY2025 number at $1.6 billion, down 65.11% from a year prior.
  • Cash & Equivalents was $1.6 billion for Q4 2025 at Costar, down from $1.9 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $5.2 billion in Q3 2023 to a low of $1.6 billion in Q4 2025.
  • A 5-year average of $4.2 billion and a median of $4.7 billion in 2022 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: soared 91.41% in 2021, then plummeted 65.11% in 2025.
  • Costar's Cash & Equivalents stood at $3.8 billion in 2021, then grew by 29.81% to $5.0 billion in 2022, then grew by 4.99% to $5.2 billion in 2023, then fell by 10.26% to $4.7 billion in 2024, then tumbled by 65.11% to $1.6 billion in 2025.
  • Per Business Quant, the three most recent readings for CSGP's Cash & Equivalents are $1.6 billion (Q4 2025), $1.9 billion (Q3 2025), and $4.7 billion (Q4 2024).